Golden Throat Holdings Group Company Limited (06896.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.95

From 52W high−48.27%

Volume166500.00

Market capHKD 1.43B

P/E (TTM)5.8x

P/S (TTM)1.4x

Div yield17.53%

Key dataSep 18, 2026

Open

HKD 1.95

From 52W high

−48.27%

Volume

166500.00

Market cap

HKD 1.43B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.9x

P/E (TTM)

5.8x

RSI (14)

21.7

MomentumView details →

1D Return

−0.51%

YTD Return

−36.39%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

5.8x

EV/EBITDA

2.9x

EV/Sales

0.9x

P/S (TTM)

1.4x

P/B (TTM)

1.0x

ProfitabilityView details →

Gross Margin

74.42%

Net Margin

23.79%

EBITDA Margin

32.88%

ROE (TTM)

17.94%

ROA (TTM)

10.08%

Asset Turnover

0.41x

GrowthView details →

Revenue YoY

−7.68%

EPS YoY

−20.97%

FCF YoY

−58.79%

Revenue CAGR 3Y

−1.67%

EPS CAGR 3Y

−3.64%

EBITDA YoY

−20.32%

MomentumView details →

1D Return

−0.51%

YTD Return

−36.39%

1Y Return

−43.93%

RSI (14)

21.7

vs 50D SMA

−29.44%

vs 200D SMA

−38.90%

Capital & dividendView details →

Debt/Equity

0.59x

Current Ratio

1.73x

Quick Ratio

1.61x

Div Yield

17.53%

Div Rate

HKD 0.34

Div Growth 1Y

−32.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.88B

Net Income (TTM)

483.29M

Op. CF (TTM)

—

Latest newsMore news →

Jin Sang Zi (06896.HK) reported interim results for the six months ended June 2026, with revenue of RMB 280 million, down 12.2% year-on-year, and net profit of RMB 47.61 million, down 43.1% year-on-year. No dividend was declared.20d ago

Jin Sang Zi (06896.HK) issued a profit warning, expecting net profit for the six months ending June to decrease by about 43% year-on-year due to increased sales expenses from expanded promotion.31d ago

Similar companies

Phibro Animal Health CorporationPAHC Dawnrays Pharmaceutical (Holdings) Limited02348.HK JBM (Healthcare) Limited02161.HK Jilin Province Huinan Changlong Bio-pharmacy Company Limited08049.HK Essex Bio-Technology Limited01061.HK Harrow Health, Inc.HROW Find similar companies →

Latest newsMore news →

Jin Sang Zi (06896.HK) reported interim results for the six months ended June 2026, with revenue of RMB 280 million, down 12.2% year-on-year, and net profit of RMB 47.61 million, down 43.1% year-on-year. No dividend was declared.20d ago Jin Sang Zi (06896.HK) issued a profit warning, expecting net profit for the six months ending June to decrease by about 43% year-on-year due to increased sales expenses from expanded promotion.31d ago